Risk of Guillain–Barré syndrome after meningococcal conjugate vaccination - Velentgas - 2012 - Pharmacoepidemiology and Drug Safety - Wiley Online Library

A distributed research network model for post-marketing safety studies: The Meningococcal Vaccine Study

Association Between Guillain-Barré Syndrome and COVID-19 Infection and Vaccination

Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination

Risk of Guillain-Barré Syndrome Following COVID-19 Vaccines

Guillain–Barré syndrome and COVID-19 vaccination: a systematic review and meta-analysis

Meningococcal Disease and Meningococcal Vaccines - ppt video online download

Availability of secondary healthcare data for conducting pharmacoepidemiology studies in Colombia: A systematic review - Franco - 2020 - Pharmacology Research & Perspectives - Wiley Online Library

Risk of Guillain–Barré syndrome after meningococcal conjugate vaccination - Velentgas - 2012 - Pharmacoepidemiology and Drug Safety - Wiley Online Library

Real-world treatment of adult patients with Guillain-Barré syndrome over the last two decades

Suitability of databases in the Asia‐Pacific for collaborative monitoring of vaccine safety - Duszynski - 2021 - Pharmacoepidemiology and Drug Safety - Wiley Online Library

Update from the International Guillain–Barré Syndrome Outcome Study (IGOS) - GBS/CIDP Foundation International

Guillain–Barré syndrome: a century of progress

Guillain-Barré syndrome in association with COVID-19 vaccination: a systematic review

PDF) Guillain-Barré Syndrome in Mexico: An Updated Review Amid the Coronavirus Disease 2019 ERA

Availability of secondary healthcare data for conducting pharmacoepidemiology studies in Colombia: A systematic review - Franco - 2020 - Pharmacology Research & Perspectives - Wiley Online Library